Nocloprost (intragastrically; 0.01-10 μg/kg) 30 min before 100% ethanol, acidified Aspirin (HY-14654), acidified Taurocholate (HY-N0545), water immersion, or restraint stress dose dependently prevents the formation of gastric lesions in rats[1].
Nocloprost (i.g.; 0.01-100 μg/kg) failes to affect gastric acid secretion or intestinal secretion (enteropooling) but preventes the increased gastroduodenal alkaline secretion[1].
Nocloprost (s.c.) shows protective activity against ethanol damage but is ineffective when applied intraduodenally[1].
| Animal Model: | 220-250 g rats[1] |
| Dosage: | 0.01-10 μg/kg |
| Administration: | Intragastrically; single dose |
| Result: | 30 min before 100% ethanol, acidified Aspirin (ASA), acidified Taurocholate, water immersion, or restraint stress dose dependently prevented the formation of gastric lesions, the ID50 values being 0.25, 0.58, 0.06 and 0.12 μg/kg in rats, respectively.
|
